These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4122443)

  • 1. The depression of quarter milk yield caused by bovine mastitis, and the response of yield to successful therapy.
    Morris RS
    Aust Vet J; 1973 Mar; 49(3):153-6. PubMed ID: 4122443
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of selective dry-cow therapy on culling rate, clinical mastitis, milk yield and cow somatic cell count. A randomized clinical field study in cows.
    Osterås O; Sandvik L
    Zentralbl Veterinarmed B; 1996 Nov; 43(9):555-75. PubMed ID: 8976620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy: one component in a mastitis control system.
    Natzke RP
    J Dairy Sci; 1971 Dec; 54(12):1895-901. PubMed ID: 4108930
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized noninferiority clinical trial evaluating 3 commercial dry cow mastitis preparations: I. Quarter-level outcomes.
    Arruda AG; Godden S; Rapnicki P; Gorden P; Timms L; Aly SS; Lehenbauer TW; Champagne J
    J Dairy Sci; 2013 Jul; 96(7):4419-35. PubMed ID: 23628244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatments at drying-off of induced and natural infections of the bovine mammary gland.
    Poutrel B
    Ann Rech Vet; 1977; 8(3):333-40. PubMed ID: 75709
    [No Abstract]   [Full Text] [Related]  

  • 6. The combination of nafcillin with penicillin and dihydrostreptomycin: subclinical trials in infected bovine quarters.
    Phillips JM
    Vet Rec; 1979 Apr; 104(16):371. PubMed ID: 95359
    [No Abstract]   [Full Text] [Related]  

  • 7. Events occurring during the previous lactation, the dry period, and peripartum as risk factors for early lactation mastitis in cows receiving 2 different intramammary dry cow therapies.
    Pinedo PJ; Fleming C; Risco CA
    J Dairy Sci; 2012 Dec; 95(12):7015-26. PubMed ID: 22999278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized noninferiority clinical trial evaluating 3 commercial dry cow mastitis preparations: II. Cow health and performance in early lactation.
    Arruda AG; Godden S; Rapnicki P; Gorden P; Timms L; Aly SS; Lehenbauer TW; Champagne J
    J Dairy Sci; 2013 Oct; 96(10):6390-9. PubMed ID: 23958025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A test model for mastitis drugs. A comparison between Abimasten and Hafpenzal.
    Grootenhuis G
    Tijdschr Diergeneeskd; 1978 Jan; 103(2):122-8. PubMed ID: 75581
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative in vitro studies of a number of anti-mastitis antibiotics.
    Van Os JL; Bakker-De Koff EC; Kraan HP
    Tijdschr Diergeneeskd; 1976 Jul; 101(14):787-95. PubMed ID: 59958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A successfully treated case of mastitis in the bovine associated with Clostridium perfringens type A.
    Johnston AM
    Vet Rec; 1986 Jun; 118(26):728-9. PubMed ID: 2426858
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of two dry cow intramammary treatments.
    Meaney WJ; Nash JM
    Vet Rec; 1977 Jun; 100(23):492-3. PubMed ID: 69358
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prepartum dry cow antibiotic treatment in dairy heifers on udder health and milk production.
    Sampimon OC; De Vliegher S; Barkema HW; Sol J; Lam TJ
    J Dairy Sci; 2009 Sep; 92(9):4395-403. PubMed ID: 19700699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of "blitz" therapy in staphylococcal and streptococcal mastitis during lactation].
    Nicolet J; Schällibaum M; Schifferli D; Schweizer R
    Schweiz Arch Tierheilkd; 1983 Jan; 125(1):31-43. PubMed ID: 6836255
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of two dry cow intramammary treatments.
    Meaney WJ
    Vet Rec; 1976 Jan; 98(3):50-1. PubMed ID: 56800
    [No Abstract]   [Full Text] [Related]  

  • 16. Viewpoint and current concepts regarding accepted and tried products for control of bovine mastitis.
    Mercer HD; Geleta JN; Baldwin RA; Shimoda W
    J Am Vet Med Assoc; 1976 Nov; 169(10):1104-14. PubMed ID: 61959
    [No Abstract]   [Full Text] [Related]  

  • 17. PERSISTENCE OF ANTIBACTERIAL AGENTS IN MILK AFTER INTRAMAMMARY TREATMENT OF CLINICAL MASTITIS.
    EBERHART RJ; WATROUS GH; HOKANSON JF; BURCH GE
    J Am Vet Med Assoc; 1963 Aug; 143():390-4. PubMed ID: 14049526
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of 2 herbal intramammary products on milk quantity and quality compared with conventional and no dry cow therapy.
    Mullen KA; Anderson KL; Washburn SP
    J Dairy Sci; 2014; 97(6):3509-22. PubMed ID: 24731642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete versus selective dry cow therapy for mastitis control.
    Rindsig RB; Rodewald RG; Smith AR; Spahr SL
    J Dairy Sci; 1978 Oct; 61(10):1483-97. PubMed ID: 81843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two regimens for the treatment of clinical bovine mastitis caused by bacteria sensitive to penicillin.
    Waage S
    Vet Rec; 1997 Dec; 141(24):616-20. PubMed ID: 9447674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.